Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
213.10
+0.60 (0.28%)
At close: Apr 28, 2026
DSE:SQURPHARMA Market Cap
DSE:SQURPHARMA has a market cap or net worth of 188.90 billion as of April 29, 2026. Its market cap has decreased by -2.65% in one year.
Market Cap
188.90B
Enterprise Value
118.95B
Revenue
81.95B
Ranking
n/a
PE Ratio
7.28
Stock Price
213.10
Market Cap Chart
Since April 18, 2002, DSE:SQURPHARMA's market cap has increased from 3.10B to 188.90B, an increase of 5,988.73%. That is a compound annual growth rate of 18.64%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 51.75B |
| Renata | 47.67B |
| Unilever Consumer Care | 40.31B |
| Beacon Pharmaceuticals | 23.15B |
| The ACME Laboratories | 15.98B |
| Asiatic Laboratories | 13.02B |
| The IBN SINA Pharmaceutical Industry | 9.73B |
| Navana Pharmaceuticals | 6.32B |